Paper42836091PubMed
Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma.
Mckiver B and 2 others. Gastrointest Disord (Basel), 2020.
Cite this record
ConductScience Library. Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma. Papers, record 42836091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42836091
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma.
- Journal
- Gastrointest Disord (Basel)
- Year
- 2020
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-07
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA230561 | NCI NIH HHS | United States | R01CA230561 | PubMed | NIH RePORTER |
| R01 CA240004 | NCI NIH HHS | United States | R01CA240004 | PubMed | NIH RePORTER |
| R01 CA244993 | NCI NIH HHS | United States | R01CA244993 | PubMed | NIH RePORTER |
| R01 DK107451 | NIDDK NIH HHS | United States | R01DK107451 | PubMed | NIH RePORTER |
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30119884 | Adenovirus armed with VGLL4 selectively kills hepatocellular carcinoma with G2/M phase arrest and apoptosis promotion. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/30119884 | PubMed |
| 2 | 19188168 | Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. | Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19188168 | PubMed |
| 3 | 20473887 | PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. | Int J Cancer | 2011 | https://conductscience.org/library/papers/20473887 | PubMed |
| 4 | 16279753 | Nanoethics: from utopian dreams and apocalyptic nightmares towards a more balanced view. | Sci Eng Ethics | 2005 | https://conductscience.org/library/papers/16279753 | PubMed |
| 5 | 26798451 | The role of AEG-1 in the development of liver cancer. | Hepat Oncol | 2015 | https://conductscience.org/library/papers/26798451 | PubMed |
| 6 | 31293335 | Immunotherapy for hepatocellular carcinoma: Current and future. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31293335 | PubMed |
| 7 | 28435396 | Lentivirus-mediated knockdown of P27RF-Rho inhibits hepatocellular carcinoma cell growth. | Contemp Oncol (Pozn) | 2017 | https://conductscience.org/library/papers/28435396 | PubMed |
| 8 | 23807724 | Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)‑2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway. | Int J Oncol | 2013 | https://conductscience.org/library/papers/23807724 | PubMed |
| 9 | 9482916 | A simplified system for generating recombinant adenoviruses. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9482916 | PubMed |
| 10 | 28430645 | Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells. | Oncotarget | 2017 | https://conductscience.org/library/papers/28430645 | PubMed |
| 11 | 27359084 | Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features. | Hepatology | 2016 | https://conductscience.org/library/papers/27359084 | PubMed |
| 12 | 29333089 | Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma in Vitro and in Vivo. | Int J Med Sci | 2018 | https://conductscience.org/library/papers/29333089 | PubMed |
| 13 | 24329792 | CAR T cells: driving the road from the laboratory to the clinic. | Immunol Rev | 2014 | https://conductscience.org/library/papers/24329792 | PubMed |
| 14 | 27535982 | Targeting Alpha-Fetoprotein (AFP)-MHC Complex with CAR T-Cell Therapy for Liver Cancer. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/27535982 | PubMed |
| 15 | 18628758 | The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. | Mol Ther | 2008 | https://conductscience.org/library/papers/18628758 | PubMed |
| 16 | 26079152 | Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC). | Bioconjug Chem | 2015 | https://conductscience.org/library/papers/26079152 | PubMed |
| 17 | 31262881 | Down-regulation of Survivin by BIX-01294 Pretreatment Overcomes Resistance of Hepatocellular Carcinoma Cells to TRAIL. | Anticancer Res | 2019 | https://conductscience.org/library/papers/31262881 | PubMed |
| 18 | 20125085 | CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. | Nat Rev Genet | 2010 | https://conductscience.org/library/papers/20125085 | PubMed |
| 19 | 29039821 | Tisagenlecleucel (Kymriah) for ALL. | Med Lett Drugs Ther | 2017 | https://conductscience.org/library/papers/29039821 | PubMed |
| 20 | 18509084 | Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. | Blood | 2008 | https://conductscience.org/library/papers/18509084 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 34687393 | Insights of CRISPR-Cas systems in stem cells: progress in regenerative medicine. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/34687393 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42836091
GET https://conductscience.org/api/papers/v1/42836091/references?page=2